ACOG Issues New Clinical Guidance for Menopause Management
The new guidelines provide updated pharmacological and non-pharmacological treatment options for menopause symptoms.
Updated on Oct. 20, 2026 in Women’s Health
Live Poll
Do current menopause treatment guidelines provide enough support for patients of all backgrounds in your area?
The American College of Obstetricians and Gynecologists released updated clinical guidance on October 15, 2026, to manage vasomotor, sleep, and mood symptoms. The recommendations aim to provide standardized, evidence-based care while addressing systemic disparities in menopause treatment.
Why it matters
The guidance serves to combat widespread misinformation and establish clear pathways for managing symptoms through shared decision-making. It highlights the importance of addressing cultural, racial, and socioeconomic barriers that have historically affected the quality of menopause care.
The clinical guidance sets parameters for hormone therapy, specifically recommending initiation before age 60 or within 10 years of menopause onset. It also identifies systemic disparities in care that persist across diverse patient populations.
The players
American College of Obstetricians and Gynecologists
This is a professional association of physicians and surgeons specializing in obstetrics and gynecology that establishes standards for women's healthcare.
The details
Physicians are encouraged to initiate discussions about menopause symptoms early and base treatment decisions on individual risks for conditions like breast cancer, cardiovascular disease, and venous thromboembolism. The guidance supports a variety of interventions, ranging from SSRIs and neurokinin receptor antagonists to non-pharmacological methods like hypnosis and acupuncture.
Timeline
October 15, 2026: The American College of Obstetricians and Gynecologists issued the new clinical guidance.
Next year: The organization plans to release a follow-up guideline specifically addressing genitourinary syndrome of menopause.
Health Landscape
This guidance marks a significant update to national medical standards, following the 2026 ACOG clinical guidance on menopause management. It shifts the focus toward a more inclusive approach that accounts for diverse patient needs and evidence-based medicine.
Patients can expect their providers to initiate conversations about symptom management earlier and use shared decision-making tools to weigh specific health risks. The guidance also discourages the use of unregulated herbal supplements in favor of scientifically validated treatments.
The takeaway
Patients should prepare to discuss specific health history, such as cardiovascular and cancer risks, with their doctors to determine the safest treatment path. Utilizing evidence-based interventions recommended by experts can help avoid ineffective or potentially unsafe over-the-counter supplements.
What happens next
A separate guideline addressing genitourinary syndrome of menopause is scheduled for release by the ACOG next year.
Further reading
For more on the latest medical standards for patients, visit the Women’s Health section.
More information
Review the official ACOG clinical guidance news release for detailed clinical recommendations.
Live Poll
Do current menopause treatment guidelines provide enough support for patients of all backgrounds in your area?
